Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

Journal of Clinical Oncology

Volumn 15, Issue 3, 1997, Pages 928-937

  Spitz, F R ^a   Abbruzzese, J L ^a   Lee, J E ^a   Pisters, P W ^a   Lowy, A M ^a   Fenoglio, C J ^a   Cleary, K R ^a   Janjan, N A ^a   Goswitz, M S ^a   Rich, T A ^a   Evans, D B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL;

EID: 0031056942     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.3.928     Document Type: Article

References (44)

1. Gastrointestinal Tumor Study Group: Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59:2006-2010, 1987
2. Kalser MH, Ellenberg SS: Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120:899-903, 1985
3. Yeo CJ, Cameron JL, Lillemore KD, et al: Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 221:721-733, 1995
4. Foo ML, Gunderson LL, Nagorney DM, et al: Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5 fluorouracil. Int J Radiat Oncol Biol Phys 26:483-489, 1993
5. Whittington R, Bryer MP, Haller DG, et al: Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 21:1137-1143, 1991
6. Griffin JF, Smalley SR, Jewell W, et al: Patterns of failure after curative resection of pancreatic carcinoma. Cancer 66:56-61, 1990
7. Tepper J, Nardi G, Suit H: Carcinoma of the pancreas. Review of MGH experience from 1963 to 1973: Analysis of surgical failure and implications for radiation therapy. Cancer 37:1519-1524, 1976
8. Westerdahl J, Andrén-Sandeberg Å, Ihse I: Recurrence of exocrine pancreatic cancer - local or hepatic? Hepatogastroenterology 40:384-387, 1993
9. Evans DB, Abbruzzese JL, Rich TA: Cancer of the pancreas, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 5). Philadelphia, PA, Lippincott, 1997, pp 1054-1087
10. Trede M, Chir B, Schwall G, et al: Survival after pancreaticoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 211:447-458, 1990
11. Willet CG, Lewandrowski K, Warshaw AL, et al: Resection margins in carcinoma of the head of the pancreas: Implications for radiation therapy. Ann Surg 217:144-148, 1993
12. Bakkevold KE, Arnesjo B, Dahl O, et al: Adjuvant combina tion chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater - results of a controlled, prospective, randomized multicentre study. Eur J Cancer 29A:698-703, 1995
13. Lieberman MD, Kilburn H, Lindsey M, et al: Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg 222:638-645, 1995
14. Ishikawa O, Ohhigashi H, Teshima T, et al: Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreaticoduodenal region. J Surg Oncol 40:143-151, 1989
15. Pilepich MV, Miller HH: Preoperative irradiation in carcinoma of the pancreas. Cancer 46:1945-1949, 1980
16. Kopelson G: Curative surgery for adenocarcinoma of the pancreas/ampulla of Vater: The role of adjuvant pre- or postoperative radiation therapy. Int J Radiat Oncol Biol Phys 9:911-915, 1983
17. Evans DB, Rich TA, Byrd DR, et al: Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 127:1335-1339, 1992
18. Hoffman JP, Weese JL, Solin LJ, et al: A single institutional experience with preoperative chemoradiation for stage I-III pancreatic adenocarcinoma. Am Surg 59:772-781, 1993
19. Jessup JM, Steele G, Mayer RJ, et al: Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 128:559-564, 1993
20. Evans DB, Staley CA, Lee JE, et al: Adenocarcinoma of the pancreas: Recent controversies, current management, and future therapies. GI Cancer 1:149-161, 1996
21. Staley CA, Lee JE, Cleary KR, et al: Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 171:118-125, 1996
22. Fuhrman GM, Charnsangavej C, Abbruzzese JL, et al: Thinsection contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg 167:104-113, 1994
23. Leach SD, Rose JA, Lowy AM, et al: Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head. Surgery 118:472-478, 1995
24. Robins DB, Katz RL, Evans DB, et al: Fine-needle aspiration of the pancreas: In quest of accuracy. Acta Cytol 39:1-10, 1995
25. Hoffman JP, Weese JL, Solin LJ, et al: Preoperative chemoradiation for patients with resectable pancreatic adenocarcinoma: An Eastern Cooperative Oncology Group (ECOG) phase II study. Proc Am Soc Clin Oncol 14:201, 1995 (abstr)
26. Ellis LM, Evans DB, Martin D, et al: Laparoscopic feeding jejunostomy tube in oncology patients. Surg Oncol 1:245-249, 1992
27. Holzman MD, Reintgen K, Broome A, et al: The role of laparoscopy in the management of pancreatic and periampullary malignancies. Gastroenterology 110:A1392, 1996 (abstr)
28. Friess H, Uhl W, Silva JC, et al: Preoperative laparoscopy: Do we need it in patients with pancreatic malignancies? Program of the Pancreas Club 1996, p 34 (abstr)
29. Evans DB, Abbruzzese JL, Cleary KR, et al: Rapid-fractionation preoperative chemoradiation for malignant periampullary neoplasms. J R Coll Surg Edinb 40:319-323, 1995
30. Evans DB, Lee JE, Pisters PWT: Pancreaticoduodenectomy (Whipple operation) and total pancreatectomy for cancer, in Nyhus LM, Baker RJ, Fishcer JF (eds): Mastery of Surgery (ed 3). Boston, MA, Little, Brown 1997, pp 1233-1249
31. Evans DB, Lee JE, Leach SD, et al: Vascular resection and intraoperative radiation therapy during pancreaticoduodenectomy: Rationale and technique. Adv Surg 29:235-262, 1996
32. Fuhrman G, Leach SD, Staley CA, et al: Rationale for enbloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal venous confluence. Ann Surg 223:154-162, 1996
33. Evans DB, Termuhlen PM, Byrd DR, et al: Intraoperative radiation therapy following pancreaticoduodenectomy. Ann Surg 218:54-60, 1993
34. Staley CA, Cleary KA, Abbruzzese JA, et al: Need for standardized pathologic staging of pancreaticoduodenectomy specimens: Pancreas. 12:373-380, 1996
35. Freeny PC, Traverso LW, Ryan JA: Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography. Am J Surg 165:600-605, 1993
36. Warshaw AL, Gu Z, Wittenberg J, et al: Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg 125:230-233, 1990
37. Robinson EK, Lee JE, Pisters PWT, et al: Reoperative pancreaticoduodenectomy for periampullary carcinoma. Am J Surg 172:432-438, 1996
38. Nitecki SS, Sarr MG, Colby TV, et al: Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221:59-66, 1995
39. Gastrointestinal Tumor Study Group: A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. Ann Surg 189:205-208, 1979
40. Roder JD, Stein HJ, Siewert R: Carcinoma of the periampullary region: Who benefits from portal vein resection? Gastroenterology 108:1242, 1995 (abstr)
41. Leach SD, Lowy AM, Fuhrman GM, et al: Pancreatic malignancy involving the superior mesenteric-portal vein confluence is not a contraindication to pancreaticoduodenectomy. Gastroenterology 108:1228, 1995 (abstr)
42. Gordon TA, Burleyson GP, Tielsch JM, et al: The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg 221:43-49, 1995
43. Neoptolemos JP, Kerr DJ: Adjuvant therapy for pancreatic cancer. Br J Surg 82:1012-1014, 1995
44. Ajani JA, Welch SR, Raber MN, et al: Comprehensive criteria for chemotherapy-induced toxicity. Cancer Invest 8:141-153, 1990